EN
HI
Ishita Drugs & Industries share price chart
Ishita Drugs & Industries Share Key Metrics
Volume
563.00
Market Cap
21.74 CR
LTQ@LTP
350@72.70
ATP
72.77
Var Margin
26.19 %
Circuit Range
60.27-90.39
Delivery %
55.08 %
Value
40969.51
ASM/GSM
No
Market Lot
1
Summary
ISHITADR stock price is ₹72.7 as of 18 Aug, 2026. The stock intraday movement has stayed between ₹72.70 and ₹75.00, while Ishita Drugs & Industries share price 52 week high low is ₹66.00 & ₹90.85.
In terms of trading activity, ISHITADR share price has recorded a volume of 563 shares. The Ishita Drugs & Industries has a market cap of ₹2990300. The stock’s Average Traded Price (ATP) stands at ₹72.77, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 350 @ ₹72.70.
The Ishita Drugs & Industries upper circuit limit is ₹90.39 & The Ishita Drugs & Industries lower circuit limit is ₹60.27, with a Value of ₹40969.51. The Delivery Percentage for the day is 55.08%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Ishita Drugs & Industries Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
63.94
Sector P/B
3.3
Sec. Div. Yield
0.51
Ishita Drugs & Industries Resistance and Support
Pivot 74.34
Resistance
First Resistance
76.78
Second Resistance
78.23
Third Resistance
80.67
Support
First Support
72.89
Second Support
70.45
Third Support
69
Ishita Drugs & Industries Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 17 2026 | 75 | 72.7 | -3.49% | 75 | 72.7 |
| Fri Aug 14 2026 | 74.88 | 75.33 | 5.80% | 75.79 | 71.9 |
| Thu Aug 13 2026 | 75 | 71.2 | -1.47% | 75.4 | 71 |
Ishita Drugs & Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-08 | Quarterly Results |
| 2026-05-30 | Audited Results |
| 2026-02-07 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-06-13 | Others |
| 2025-05-30 | Audited Results |
| 2025-02-13 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Ishita Drugs & Industries News
Ishita Drugs & Industries Ltd - 524400 - Board Meeting Outcome for Outcome Of Board Meeting Held On 08Th August, 2026
Ishita Drugs & Industries board approved Q1 FY27 financial results, reporting a net profit of ₹23.02 lacs, down from ₹30.23 lacs YoY, and revenue of ₹314.53 lacs, down from ₹540.05 lacs YoY. The board also approved the re-appointment of Mrs. Abha Agrawal as Non-Executive Non-Independent Director.
Aug 08 2026 15:35:25
Ishita Drugs & Industries Ltd - 524400 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 For The Quarter Ended 30Th June, 2026.
Ishita Drugs & Industries board meeting scheduled for August 8, 2026. The agenda includes considering and approving the unaudited financial results for the quarter ended June 30, 2026. This meeting will finalize the company's financial performance for Q1 FY27.
Jul 31 2026 13:56:17
Ishita Drugs & Industries Management
| Name | Position |
|---|---|
| Jagdish Agrawal | Managing Director |
| Abha Agrawal | Non Executive Director |
Ishita Drugs & Industries Similar Stocks
Gujarat Terce Laboratories Ltd.
39.75
1.05 (2.71%)
Tejnaksh Healthcare Ltd.
13.12
-0.26 (1.94%)
Gujarat Inject (Kerala) Ltd.
13.29
0.63 (4.98%)
Bacil Pharma Ltd.
12.47
-0.65 (4.95%)
Cian Healthcare Ltd.
9.55
0.00 (0.00%)
Emmessar Biotech & Nutrition Ltd.
23.90
0.22 (0.93%)
Beryl Drugs Ltd.
23.00
0.05 (0.22%)
Sharma East India Hospitals & Medical Research Ltd
97.00
0.50 (0.52%)
Norris Medicines Ltd.
15.58
-0.32 (2.01%)
Ishita Drugs & Industries FAQs
The Buying Price of Ishita Drugs & Industries share is 72.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ishita Drugs & Industries stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ishita Drugs & Industries, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ishita Drugs & Industries shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ishita Drugs & Industries shares is 0. Useful to assess the stock's value relative to its book value.
To assess Ishita Drugs & Industries’s valuation compare Sector P/E, P/B which are 63.94 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ishita Drugs & Industries is 21.74 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ishita Drugs & Industries share price is 90.85 & 66.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ishita Drugs & Industries belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
